By Reuters Staff
(Recasts with senior official comments on Sinovac vaccine)
BANGKOK, Jan 13 (Reuters) - Thailand on Wednesday said it was still on track to receive and administer a coronavirus vaccine by China’s Sinovac Biotech starting next month, despite data from a Brazil trial that showed 50.4% efficiency, health officials said.
“There is no impact on our plan right now,” Supakit Sirilak, Director-General of Medical Science Department, told a briefing when asked about Brazil’s data.
“We are asking for information directly from Sinovac, so we are waiting for their response to get all the facts,” he said.
Thailand, which has reported a total of 10,991 infections and 67 fatalities since it detected its first case a year ago, has ordered 2 million doses of Sinovac’s CoronaVac and expects to receive the first 200,000 doses next month.
AstraZeneca vaccine approval expected
published : 19 Jan 2021 at 06:50
69 A nurse displays a vial of AstraZeneca s COVISHIELD vaccine during the coronavirus disease vaccination campaign at a medical centre in Mumbai on Saturday. (Reuters photo)
The Food and Drug Administration (FDA) is expected to approve the Oxford-AstraZeneca Covid-19 vaccine this week for emergency use.
Dr Opas Karnkawinpong, director-general of the Ministry of Public Health s Disease Control Department (DCD), said on Monday the FDA was examining documents submitted to it to prove the efficacy and safety of a Covid-19 vaccine .
Dr Surachoke Tangwiwat, deputy secretary-general of the FDA, later confirmed it was the vaccine produced by Oxford University and AstraZeneca, a British-Swedish multinational pharmaceutical and biopharmaceutical company.
AstraZeneca vaccine approval expected
published : 19 Jan 2021 at 06:50
69 A nurse displays a vial of AstraZeneca s COVISHIELD vaccine during the coronavirus disease vaccination campaign at a medical centre in Mumbai on Saturday. (Reuters photo)
The Food and Drug Administration (FDA) is expected to approve the Oxford-AstraZeneca Covid-19 vaccine this week for emergency use.
Dr Opas Karnkawinpong, director-general of the Ministry of Public Health s Disease Control Department (DCD), said on Monday the FDA was examining documents submitted to it to prove the efficacy and safety of a Covid-19 vaccine .
Dr Surachoke Tangwiwat, deputy secretary-general of the FDA, later confirmed it was the vaccine produced by Oxford University and AstraZeneca, a British-Swedish multinational pharmaceutical and biopharmaceutical company.
Thailand on Wednesday said it was still on track to receive and administer a coronavirus vaccine by China's Sinovac Biotech starting next month, despite data from a Brazil trial that showed 50.4% efficiency, health officials said.
BANGKOK (Reuters): Thailand on Wednesday (Jan 12) said it was still on track to receive and administer a coronavirus vaccine by China's Sinovac Biotech starting next month, despite data from a Brazil trial that showed 50.4% efficiency, health officials said.